Aclipse Therapeutics is an innovative biopharmaceutical company focused on developing novel and highly differentiated drugs to address rare diseases with high unmet medical needs.

Aclipse develops innovative drug products based on a combination of new and druggable understandings of disease pathways with a novel form of an existing drug that inhibits these pathways.

See More intellectual digital
companies
Learn more about
Aclipse Therapeutics